Cargando…

Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients

Venous thromboembolism (VTE), clinically presenting as deep vein thrombosis (DVT) or pulmonary embolism (PE). Not all DVT patients carry the same risk of developing acute pulmonary embolism (APE). To develop and validate a prediction model to estimate risk of APE in DVT patients combined with past m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, You, He, Yuncong, Meng, Yan, Fu, Bowen, Xue, Shuanglong, Kang, Mengyang, Duan, Zhenzhen, Chen, Yan, Wang, Yifan, Tian, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758720/
https://www.ncbi.nlm.nih.gov/pubmed/35027609
http://dx.doi.org/10.1038/s41598-021-04657-y
_version_ 1784632974735572992
author Li, You
He, Yuncong
Meng, Yan
Fu, Bowen
Xue, Shuanglong
Kang, Mengyang
Duan, Zhenzhen
Chen, Yan
Wang, Yifan
Tian, Hongyan
author_facet Li, You
He, Yuncong
Meng, Yan
Fu, Bowen
Xue, Shuanglong
Kang, Mengyang
Duan, Zhenzhen
Chen, Yan
Wang, Yifan
Tian, Hongyan
author_sort Li, You
collection PubMed
description Venous thromboembolism (VTE), clinically presenting as deep vein thrombosis (DVT) or pulmonary embolism (PE). Not all DVT patients carry the same risk of developing acute pulmonary embolism (APE). To develop and validate a prediction model to estimate risk of APE in DVT patients combined with past medical history, clinical symptoms, physical signs, and the sign of the electrocardiogram. We analyzed data from a retrospective cohort of patients who were diagnosed as symptomatic VTE from 2013 to 2018 (n = 1582). Among them, 122 patients were excluded. All enrolled patients confirmed by pulmonary angiography or computed tomography pulmonary angiography (CTPA) and compression venous ultrasonography. Using the LASSO and logistics regression, we derived a predictive model with 16 candidate variables to predict the risk of APE and completed internal validation. Overall, 52.9% patients had DVT + APE (773 vs 1460), 47.1% patients only had DVT (687 vs 1460). The APE risk prediction model included one pre-existing disease or condition (respiratory failure), one risk factors (infection), three symptoms (dyspnea, hemoptysis and syncope), five signs (skin cold clammy, tachycardia, diminished respiration, pulmonary rales and accentuation/splitting of P(2)), and six ECG indicators (S(I)Q(III)T(III), right axis deviation, left axis deviation, S(1)S(2)S(3), T wave inversion and Q/q wave), of which all were positively associated with APE. The ROC curves of the model showed AUC of 0.79 (95% CI, 0.77–0.82) and 0.80 (95% CI, 0.76–0.84) in the training set and testing set. The model showed good predictive accuracy (calibration slope, 0.83 and Brier score, 0.18). Based on a retrospective single-center population study, we developed a novel prediction model to identify patients with different risks for APE in DVT patients, which may be useful for quickly estimating the probability of APE before obtaining definitive test results and speeding up emergency management processes.
format Online
Article
Text
id pubmed-8758720
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87587202022-01-14 Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients Li, You He, Yuncong Meng, Yan Fu, Bowen Xue, Shuanglong Kang, Mengyang Duan, Zhenzhen Chen, Yan Wang, Yifan Tian, Hongyan Sci Rep Article Venous thromboembolism (VTE), clinically presenting as deep vein thrombosis (DVT) or pulmonary embolism (PE). Not all DVT patients carry the same risk of developing acute pulmonary embolism (APE). To develop and validate a prediction model to estimate risk of APE in DVT patients combined with past medical history, clinical symptoms, physical signs, and the sign of the electrocardiogram. We analyzed data from a retrospective cohort of patients who were diagnosed as symptomatic VTE from 2013 to 2018 (n = 1582). Among them, 122 patients were excluded. All enrolled patients confirmed by pulmonary angiography or computed tomography pulmonary angiography (CTPA) and compression venous ultrasonography. Using the LASSO and logistics regression, we derived a predictive model with 16 candidate variables to predict the risk of APE and completed internal validation. Overall, 52.9% patients had DVT + APE (773 vs 1460), 47.1% patients only had DVT (687 vs 1460). The APE risk prediction model included one pre-existing disease or condition (respiratory failure), one risk factors (infection), three symptoms (dyspnea, hemoptysis and syncope), five signs (skin cold clammy, tachycardia, diminished respiration, pulmonary rales and accentuation/splitting of P(2)), and six ECG indicators (S(I)Q(III)T(III), right axis deviation, left axis deviation, S(1)S(2)S(3), T wave inversion and Q/q wave), of which all were positively associated with APE. The ROC curves of the model showed AUC of 0.79 (95% CI, 0.77–0.82) and 0.80 (95% CI, 0.76–0.84) in the training set and testing set. The model showed good predictive accuracy (calibration slope, 0.83 and Brier score, 0.18). Based on a retrospective single-center population study, we developed a novel prediction model to identify patients with different risks for APE in DVT patients, which may be useful for quickly estimating the probability of APE before obtaining definitive test results and speeding up emergency management processes. Nature Publishing Group UK 2022-01-13 /pmc/articles/PMC8758720/ /pubmed/35027609 http://dx.doi.org/10.1038/s41598-021-04657-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Li, You
He, Yuncong
Meng, Yan
Fu, Bowen
Xue, Shuanglong
Kang, Mengyang
Duan, Zhenzhen
Chen, Yan
Wang, Yifan
Tian, Hongyan
Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients
title Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients
title_full Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients
title_fullStr Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients
title_full_unstemmed Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients
title_short Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients
title_sort development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758720/
https://www.ncbi.nlm.nih.gov/pubmed/35027609
http://dx.doi.org/10.1038/s41598-021-04657-y
work_keys_str_mv AT liyou developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT heyuncong developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT mengyan developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT fubowen developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT xueshuanglong developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT kangmengyang developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT duanzhenzhen developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT chenyan developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT wangyifan developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients
AT tianhongyan developmentandvalidationofapredictionmodeltoestimateriskofacutepulmonaryembolismindeepveinthrombosispatients